GSK3277511A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK3277511A, covering 2018-07-23 to 2021-09-27. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine [Phase 2]